Vertex Pharmaceuticals (VRTX) Goodwill (2009 - 2026)

Vertex Pharmaceuticals has reported Goodwill for 18 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Goodwill changed 0.0% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 0.0% change from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 1.09% from the prior year.
• Goodwill was $1.1 billion for Q2 2026 at Vertex Pharmaceuticals, roughly flat from $1.1 billion in the prior quarter.
• The five-year high for Goodwill was $1.1 billion in Q4 2022, with the low at $1.0 billion in Q1 2022.
• Average Goodwill over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Goodwill rose 9.76% in 2022, then fell 1.09% in 2025.
• Over 5 years, Goodwill stood at $1.1 billion in 2022, then changed by 0.0% to $1.1 billion in 2023, then changed by 0.0% to $1.1 billion in 2024, then decreased by 1.09% to $1.1 billion in 2025, then changed by 0.0% to $1.1 billion in 2026.
• The last three Goodwill figures came in at $1.1 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.